Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2005
12/22/2005WO2005121785A2 System for monitoring physiological characteristics according to the user biological state
12/22/2005WO2005121784A1 Medical image processing system
12/22/2005WO2005121783A1 Method and device for inspecting drill core samples
12/22/2005WO2005121782A1 Fluid monitoring systems and methods with data communication to interested parties
12/22/2005WO2005121781A1 Relative humidity sensor
12/22/2005WO2005121780A2 Methods and apparatus for characterizing, measuring, and dispensing fluids
12/22/2005WO2005121779A1 Electro-chemical sensor
12/22/2005WO2005121778A2 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
12/22/2005WO2005121762A1 Micro-band electrode manufacturing method
12/22/2005WO2005121761A1 Gas sensor for determining ammonia
12/22/2005WO2005121759A2 Device and method for analyte measurement
12/22/2005WO2005121758A1 Biomarkers for peripheral artery disease
12/22/2005WO2005121755A1 Cell free g-protein coupled receptor and ligand assay
12/22/2005WO2005121751A1 Ir-sensor, particularly a co2 sensor
12/22/2005WO2005121380A1 Predictive biomarkers in cancer therapy
12/22/2005WO2005121374A2 Molecular analysis of hair follicles for disease
12/22/2005WO2005121366A1 Gene marker and utilization of the same
12/22/2005WO2005121363A2 Method for determining biophysical properties
12/22/2005WO2005121356A1 Novel screening method
12/22/2005WO2005121355A1 Analyte sensors and methods for making and using them
12/22/2005WO2005121341A1 Tumor specific antibody
12/22/2005WO2005121339A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005WO2005121338A1 Anti-perp antibody
12/22/2005WO2005121336A1 Method of purifying environmental dna and method of efficiently screening protein-encoding gene from environmental dna
12/22/2005WO2005121322A1 Enzymatic modification of cell-surface h antigen by glycosyltransferases
12/22/2005WO2005121320A1 Autonomouos replication promoter for stem cells
12/22/2005WO2005121172A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/22/2005WO2005121170A1 Abc transporter protein that confers resistance to bacitracin in interococci
12/22/2005WO2005121166A1 Novel immunointeractive molecules and uses thereof
12/22/2005WO2005120691A1 Reactor mixing
12/22/2005WO2005120620A2 Durable hydrophilic mouldable polymer composition, aqueous fluid channels based on said composition, microfluidic system incorporating said channels and method for the production thereof
12/22/2005WO2005120553A2 Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues
12/22/2005WO2005120547A1 Use of neuregulin-3 for inducing mammary cell differentiation and for the treatment of breast cancer
12/22/2005WO2005120518A2 Use of atp analogues for treatment of cardiovascular diseases
12/22/2005WO2005120231A1 Connective tissue growth factor regulates intracellular signaling pathways
12/22/2005WO2005120195A2 Reservoir simulation
12/22/2005WO2005111553A3 Method for compensation of near-neighbor sample effects in a nmr check weighing system
12/22/2005WO2005107491A3 Multi-lectin affinity chromatography and uses thereof
12/22/2005WO2005104763A3 Improved method for identifying peptides in a biological sample
12/22/2005WO2005103738A3 Bi-directional three-dimensional microwave scanning and volumetric mapping of a whole roll or pallet of paper
12/22/2005WO2005101956A3 Method of identifying therapeutic compounds which can be used for the treatment and/or prevention of infections and diseases caused by human herpesviruses
12/22/2005WO2005096706A3 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
12/22/2005WO2005095959A3 Methods for treating dermatological conditions in a patient
12/22/2005WO2005094533A3 Trail-r as a negative regulator of innate immune cell responses
12/22/2005WO2005089509A3 High throughput assay systems and methods for identifying agents that alter expression of cellular proteins
12/22/2005WO2005086784A3 Method and apparatus for measuring changes in cell volume
12/22/2005WO2005083107A3 Inhibition of superoxide dismutase by tetrathiomolybdate: identification of new anti-angiogenic and antitumor agents
12/22/2005WO2005079278A3 High throughput screening methods for lubricating oil compositions
12/22/2005WO2005079135A3 Method and device for the determination of several analytes with simultaneous internal verification in a graphical combination
12/22/2005WO2005077065A3 Selective high-affinity polydentate ligands and methods of making such
12/22/2005WO2005076887A3 Methods and systems for sampling, screening, and diagnosis
12/22/2005WO2005070456A8 Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies
12/22/2005WO2005067569A3 Method and apparatus for detecting hydrocarbons with nmr logs in wells drilled with oil-based muds
12/22/2005WO2005067477A3 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
12/22/2005WO2005061537A3 Squamous cell carcinoma antigens and use thereof
12/22/2005WO2005047326A3 Interleukin-10 antibodies
12/22/2005WO2005043464A3 Dynamic crop box determination for optimized display of a tube-like structure in endoscopic view (“crop box”)
12/22/2005WO2005042029A3 Psma formulations and uses thereof
12/22/2005WO2005034737A3 Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases
12/22/2005WO2005028663A3 Operator independent programmable sample preparation and analysis system
12/22/2005WO2005013912A3 Anti-fcrn antibodies for treatment of auto/allo immune conditions
12/22/2005WO2005012482B1 Assay for identification of bioactive compounds that interact with heat shock protein 90
12/22/2005WO2004104576A8 Device for conveying a fluid volume, device and method for the analysis thereof
12/22/2005WO2004091379A3 Assessing neuronal damage from blood samples
12/22/2005WO2004085621A3 Gene expression in breast cancer
12/22/2005WO2004082370A3 Cardiac-preferred genetic alteration of transgenic rabbits
12/22/2005WO2004078948A3 METHOD TO IDENTIFY REGULATORS OF CELLULAR ACTIVATION USING Bcl10
12/22/2005WO2004070004A3 Rat receptor tyrosine kinase, kdr
12/22/2005WO2004055857A3 Method for producing a sample carrier for maldi-mass spectrometry
12/22/2005WO2004044175A3 Fluorescence guided cell capture
12/22/2005WO2004041160A3 Methods and animal model for analyzing age-related macular degeneration
12/22/2005WO2004030511A3 Prostate cancer biomarkers
12/22/2005WO2004021242A3 Amino acid sequence pattern matching
12/22/2005WO2004020610A3 Methods and compositions for modulating xbp-1 activity
12/22/2005WO2004005483A3 ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050283841 Inhibition of protein kinase C-related kinase (PRK) as a treatment for cardiac hypertrophy and heart failure
12/22/2005US20050283320 Method and system for profiling biological systems
12/22/2005US20050283316 Silico iterations correlating mass spectrometer outputs with peptides in databases and success of same
12/22/2005US20050283057 Micro-invasive method for painless detection of analytes in extracellular space
12/22/2005US20050283003 Reversible immobilization of arginine-tagged moieties on a silicate surface
12/22/2005US20050282999 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
12/22/2005US20050282743 Molecular interactions in cells
12/22/2005US20050282740 Methods and compositions for regulating protein-protein interactions
12/22/2005US20050282736 ligating recombinant intein domains to a linear synthetic protein to form a compound D1-X(n)-D2, where D1 and D2 are catalytic domains of an intein and X is a protein; cell-free; producing small cyclic peptides containing non-genetically encodable amino acids; for drugs
12/22/2005US20050282294 Affinity supports with immobilised protein A
12/22/2005US20050282286 Method for determining organically bound carbon (TOC)
12/22/2005US20050282274 Osteoblast precursors from human embryonic stem cells
12/22/2005US20050282246 includes frozen tissue cores that extend from the top of the tissue microarray to a release; release is a material from which embedding material of the tissue microarray can easily be removed; stiffener is used with release to maintain flat shape
12/22/2005US20050282245 Use of a composition which regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process
12/22/2005US20050282240 Method for identifying peptides in a biological sample
12/22/2005US20050282238 High-sensitivity chemiluminescent ELISA prion detection method
12/22/2005US20050282237 Immunological analysis carrier and an immunological analysis method using the same
12/22/2005US20050282235 Process and device for producing reagent carriers
12/22/2005US20050282234 Diagnosis and/or monitoring of patients with systemic lupus erythematosus by isolating reticulocytes from a blood sample, determining the level of a C4d complement pathway component on the reticulocytes, and comparing it to a control level; an elevated lovel indicates an acute inflammatory episode
12/22/2005US20050282233 Multivalent antibody materials and methods for VEGF/PDGF family of growth factors
12/22/2005US20050282232 Screening for modulators of subcellular location of c-Rel protein in cells; identifying modulators of autoimmune/inflammatory disorders
12/22/2005US20050282231 Screening assays for hedgehog agonists and antagonists
12/22/2005US20050282230 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method